Department of Health Professions
Board of Medicine
Regulations Governing Prescribing of Opioids and Buprenorphine
[18 VAC 85 ‑ 21]
Public Petition for Rulemaking: Replace naloxone co-prescription requirement with FDA-approved opioid-reversal agents
CLOSED Opened on 8/29/2022 and Ended on 9/19/2022
View all comments
2 comments
| Comment Title | Commenter | |
|---|---|---|
| Comments in Support of Petition 372 | Todd Lacksonen, Opiant Pharmaceuticals | 9/19/22 2:34 pm |
| Updating the term "Naloxone" | Victor McKenzie Jr | 9/19/22 2:24 pm |
Trouble posting comments? These pages have been tested with multiple versions of all the major browsers.
If you have trouble: (1) try another computer if you have access to one, (2) try another browser if your computer has one installed (3) contact
Town Hall support staff for assistance.